Shattuck Labs Inc (STTK)
1.42
+0.20
(+16.39%)
USD |
NASDAQ |
Nov 14, 12:55
Shattuck Labs Enterprise Value: -47.12M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 13, 2024 | -47.12M |
November 12, 2024 | -45.21M |
November 11, 2024 | -49.03M |
November 08, 2024 | -49.03M |
November 07, 2024 | -46.16M |
November 06, 2024 | -46.64M |
November 05, 2024 | -48.07M |
November 04, 2024 | -49.98M |
November 01, 2024 | -45.68M |
October 31, 2024 | -45.21M |
October 30, 2024 | -42.82M |
October 29, 2024 | -41.39M |
October 28, 2024 | -40.67M |
October 25, 2024 | -42.82M |
October 24, 2024 | -44.25M |
October 23, 2024 | -43.30M |
October 22, 2024 | -44.25M |
October 21, 2024 | -45.68M |
October 18, 2024 | -40.91M |
October 17, 2024 | -39.48M |
October 16, 2024 | -36.14M |
October 15, 2024 | -34.23M |
October 14, 2024 | -30.89M |
October 11, 2024 | -31.84M |
October 10, 2024 | -35.18M |
Date | Value |
---|---|
October 09, 2024 | -38.53M |
October 08, 2024 | -45.21M |
October 07, 2024 | -51.41M |
October 04, 2024 | -47.12M |
October 03, 2024 | -44.25M |
October 02, 2024 | -45.68M |
October 01, 2024 | -13.71M |
September 30, 2024 | 61.22M |
September 27, 2024 | 79.36M |
September 26, 2024 | 72.20M |
September 25, 2024 | 67.91M |
September 24, 2024 | 71.25M |
September 23, 2024 | 68.38M |
September 20, 2024 | 73.16M |
September 19, 2024 | 71.25M |
September 18, 2024 | 68.86M |
September 17, 2024 | 73.63M |
September 16, 2024 | 70.77M |
September 13, 2024 | 76.50M |
September 12, 2024 | 70.77M |
September 11, 2024 | 72.68M |
September 10, 2024 | 78.88M |
September 09, 2024 | 68.38M |
September 06, 2024 | 61.70M |
September 05, 2024 | 63.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-124.80M
Minimum
May 26 2022
2.270B
Maximum
Dec 24 2020
282.18M
Average
40.27M
Median
Jan 12 2022
Enterprise Value Benchmarks
CVS Health Corp | 124.31B |
Johnson & Johnson | 384.40B |
Bristol-Myers Squibb Co | 160.18B |
IGM Biosciences Inc | 409.17M |
Biohaven Ltd | 4.199B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -21.55M |
Revenue (Quarterly) | 1.609M |
Total Expenses (Quarterly) | 24.57M |
EPS Diluted (Quarterly) | -0.42 |
Profit Margin (Quarterly) | -1.34K% |
Earnings Yield | -130.3% |
Normalized Earnings Yield | -130.28 |